Teva woes continue amid congressional probe, negative outlook

According to the May lawsuit filed by Connecticut Attorney-General William Tong, Teva significantly raised prices on approximately 112 different generic drugs between July 2013 and January 2015.

The CEO of Teva Pharmaceutical Industries Kare Schultz speaks during a news conference to discuss the company's 2019 outlooks in Tel Aviv, Israel February 19, 2019

(photo credit: AMIR COHEN/REUTERS)

ByEYTAN HALON, REUTERS

AUGUST 15, 2019 22:58

Teva woes continue amid congressional probe, negative outlook

According to the May lawsuit filed by Connecticut Attorney-General William Tong, Teva significantly raised prices on approximately 112 different generic drugs between July 2013 and January 2015.

IDF reservist killed in car accident

Israeli military kills approaching terrorists in Gaza

Teva woes continue amid congressional probe, negative outlook

According to the May lawsuit filed by Connecticut Attorney-General William Tong, Teva significantly raised prices on approximately 112 different generic drugs between July 2013 and January 2015.

See more on